Literature DB >> 28994383

[The complement system: a double edge sword in tumor progression].

Marie Daugan1, Remi Noe2, Wolf Herman Fridman3, Catherine Sautes-Fridman3, Lubka T Roumenina1.   

Abstract

The complement system is a key component of the innate immunity, playing a role in pathogen elimination and in host homeostasis. The complement system has been considered for long time as an anti-tumoral element. However, recent studies showed a pro-tumoral effect of complement and particularly of the anaphylatoxines C3a and C5a in a large variety of tumor types. Complement proteins act on different levels of tumor progression, affecting the tumor cells, the angiogenesis and the immune microenvironment. The impact of the complement system on tumor progression seems to be cancer type-dependent and this has to be taken into account in the establishment of potential biomarkers and development of therapeutic strategies.
© 2017 médecine/sciences – Inserm.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28994383     DOI: 10.1051/medsci/20173310019

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  1 in total

1.  Complement C7 is Specifically Expressed in Mesangial Cells and is a Potential Diagnostic Biomarker for Diabetic Nephropathy and is Regulated by miR-494-3p and miR-574-5p.

Authors:  Hang Guo; Zhiyue Yan; Yonghui Hu; Xitong Huang; Congqing Pan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-05       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.